Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Certainty comes too late

In the first of a new regular column, Professor Brian D Smith points out the practical implications of an evolving pharma market

Novartis building

FDA panel rejects Novartis’ heart failure hope serelaxin

Decision follows EMA knock back earlier this year

- PMLiVE

Pfizer gains ground in cholesterol antibody chase

 Reports positive phase 2b data for its PCSK9 blocker

- PMLiVE

Online Parkinson’s platform could revolutionise chronic disease care

ParkinsonNet connects patients with doctors in a virtual setting

- PMLiVE

EMA’s Dr Stella Blackburn joins Quintiles

Takes up global head of risk management post

- PMLiVE

Baxter splits in two, spinning off biotech business

The 'new' Baxter will focus on medical products

National Institute for Health and Care Excellence NICE logo

NICE consults on value-based assessment changes

Aims to create a more flexible approach to drug funding decisions for NHS in England and Wales

- PMLiVE

Final NICE backing for MabThera in rare condition

Roche drug available in England and Wales to treat rare form of vasculitis

- PMLiVE

EMA clears GSK’s diabetes therapy Eperzan

Once-weekly GLP-1 therapy will line-up against Victoza and Byetta

- PMLiVE

Merck KGaA loses global head of R&D

Senior reshuffle also sees departure of head of Merck Millipore

- PMLiVE

EFPIA hires director of European affairs

Elizabeth Kuiper will join trade body on May 1

- PMLiVE

AstraZeneca launches delivery service for Nexium

Expands its US direct-to-patient programme

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links